T. Rowe Price Associates’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$264M Buy
2025
Q2
$290M Buy
2025
Q1
$172M Buy
2024
Q4
$73.3M Buy
2024
Q3
$66.1M Buy
2024
Q2
$19.5M Buy
2024
Q1
$6.53M Buy